The later scenario is illustrated by Patient 4, who presented with endometrial adenocarcinoma and absence of PMS2 protein and presence of MSH2, MSH6 and MLH1 protein on IHC. This evidence concerns the gene PMS2 and endometrium adenocarcinoma.